Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +236.37%
#3 ONFA ONFA +54.06%
#4 Metaplex Metaplex +23.53%
#5 Wrapped Krown Wrapped Krown +19.97%
#6 Osaka Protocol Osaka Protocol +18.53%
#7 Talus Network Talus Network +17.86%
#8 DODO DODO +17.35%
#9 Magma Finance Magma Finance +15.62%
#10 Black Phoenix Black Phoenix +15.03%
Coin of the day
DeFiChain DeFiChain
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Kedudukan dalam Saham #16324
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Harga Saham
$0.94180721
Modal Pasaran
$22.26M
Perubahan (1 hari)
0.38%
Perubahan (1 tahun)
-14.35%
Negara
FR
Perdagangan Valbiotis SA (ALVAL)

Kategori

Healthcare
Bilangan saham terbitan bagi Valbiotis SA (ALVAL)
Bilangan saham terbitan setakat December 2025: 23.69M
Menurut laporan kewangan terkini dan harga saham Valbiotis SA, bilangan saham terbitan semasa ialah 23.69M. Pada akhir December 2023, syarikat mempunyai 12.46M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Valbiotis SA (ALVAL) dari 2015 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 23.69M 50.02%
2024 15.79M 26.74%
2023 12.46M 23.21%
2022 10.11M 10.45%
2021 9.16M 22.88%
2020 7.45M 58.63%
2019 4.70M 24.66%
2018 3.77M 42.50%
2017 2.64M -26.12%
2016 3.58M 29,318.19%
2015 12.17K 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 18,649.65%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 972.42%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 338.93%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 701.88%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 159.22%
NL